To assess the tendency of osteoclast differentiation in multiple myeloma, we prepared PBMCs from blood obtained from healthy individuals and patients with multiple myeloma and differentiated them into osteoclasts in the presence of M-CSF and RANKL stimulation. The gene discussed is CSF1; the disease is plasma cell myeloma.